Spring Bank Pharmaceuticals (United States)

Recent papers from Spring Bank Pharmaceuticals (United States)

1. ID #479 Use of Mirdametinib for the Treatment of Neurofibromatosis Type 1–Associated Plexiform Neurofibromas (NF1-PN) in Patients with Prior Mitogen-Activated Protein Kinase (MAPK) Kinase Inhibitor (MEKi) ExposureNeuro-Oncology Pediatrics · 2026
2. Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United StatesCancer Research Communications · 2026
3. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κBCommunications Biology · 2022
4. NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in MiceFrontiers in Immunology · 2020
5. Nucleobase Protection of Deoxyribo‐ and RibonucleosidesCurrent Protocols in Nucleic Acid Chemistry · 2017
6. SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variantsJournal of Medical Virology · 2017
7. Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in WoodchucksPLoS ONE · 2017
8. Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold testsF1000Research · 2016
9. Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis BPLoS ONE · 2016
10. In silicooptimization of pharmacokinetic properties and receptor binding affinity simultaneously: a ‘parallel progression approach to drug design’ applied to β-blockersJournal of Biomolecular Structure and Dynamics · 2015
11. Identification of new checkpoint kinase-1 (Chk1) inhibitors by docking, 3D-QSAR, and pharmacophore-modeling methodsCanadian Journal of Chemistry · 2012
12. Synthesis of a ³⁵S‐labeled dinucleoside phosphorothioate prodrug, an orally bioavailable anti‐HBV agentJournal of Labelled Compounds and Radiopharmaceuticals · 2012
13. EnsembleQSAR: A QSAR method based on conformational ensembles and metric descriptorsJournal of Computational Chemistry · 2011
14. Assessing the Risk to Nontarget Organisms from Bt Corn Resistant to Corn Rootworms (Coleoptera: Chrysomelidae): Tier-I Testing with Orius insidiosus (Heteroptera: Anthocoridae)Environmental Entomology · 2008
15. Development of Tier-I Toxicity Assays for Orius insidiosus (Heteroptera: Anthocoridae) for Assessing the Risk of Plant-Incorporated Protectants to Nontarget HeteropteransEnvironmental Entomology · 2007
16. Development of Tier-I Toxicity Assays forOrius insidiosus(Heteroptera: Anthocoridae) for Assessing the Risk of Plant-Incorporated Protectants to Nontarget HeteropteransEnvironmental Entomology · 2007
17. Time dependence of phase distribution of pyrethroid insecticides in sedimentEnvironmental Toxicology and Chemistry · 2006
18. Microwave‐Assisted Functionalization of Solid Supports for Rapid Loading of NucleosidesCurrent Protocols in Nucleic Acid Chemistry · 2005
19. Icon® rice seed treatment toxicity to crayfish (Procambarus clarkii) in experimental rice paddiesEnvironmental Toxicology and Chemistry · 2003
20. Ecological Risks of Diazinon from Agricultural Use in the Sacramento – San Joaquin River Basins, CaliforniaRisk Analysis · 2000